Skip to main content

MARK SHEPTOFF FINANCIAL PLANNING, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1607355 GLASTONBURY, CT

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$12,523
+$7,030 QoQ
Shares Held
160
+88.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#553
of 647 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARK SHEPTOFF FINANCIAL PLANNING, LLC holds $4,912,100 across 16 Biotechnology names. HALO ranks #5 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 HALO
Halozyme Therapeutics, Inc.
This page
160 $12,523

All Filings in HALO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,523 160
2026-03-31 $5,493 85
2025-12-31 $15,815 235
2025-09-30 $75,906 1,035
2025-06-30 $6,970 134
2025-03-31 $5,423 85
2024-12-31 $4,063 85
2024-09-30 $4,865 85
2024-06-30 $4,450 85
2024-03-31 $3,457 85